The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-12

Treatment Strategy for Hodgkin Lymphoma

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Kiyohiko Hatake (Department of Hematology, International University of Health and Welfare, Mita hospital)

Sponsor: Takeda Pharmaceutical Company Limited

[MS2-12] Treatment Strategy for Hodgkin Lymphoma

Kenichi Ishizawa (Department of Third Internal Medicine, Yamagata University Faculty of Medicine)